Cargando…
Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome
BACKGROUND: Down syndrome (DS) is a complex disorder caused by the trisomy of either the entire, or a critical region of chromosome 21 (21q22.1-22.3). Despite representing the most common cause of mental retardation, the molecular bases of the syndrome are still largely unknown. METHODS: To better u...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717290/ https://www.ncbi.nlm.nih.gov/pubmed/23830204 http://dx.doi.org/10.1186/1755-8794-6-24 |
_version_ | 1782277682712543232 |
---|---|
author | Granese, Barbara Scala, Iris Spatuzza, Carmen Valentino, Anna Coletta, Marcella Vacca, Rosa Anna De Luca, Pasquale Andria, Generoso |
author_facet | Granese, Barbara Scala, Iris Spatuzza, Carmen Valentino, Anna Coletta, Marcella Vacca, Rosa Anna De Luca, Pasquale Andria, Generoso |
author_sort | Granese, Barbara |
collection | PubMed |
description | BACKGROUND: Down syndrome (DS) is a complex disorder caused by the trisomy of either the entire, or a critical region of chromosome 21 (21q22.1-22.3). Despite representing the most common cause of mental retardation, the molecular bases of the syndrome are still largely unknown. METHODS: To better understand the pathogenesis of DS, we analyzed the genome-wide transcription profiles of lymphoblastoid cell lines (LCLs) from six DS and six euploid individuals and investigated differential gene expression and pathway deregulation associated with trisomy 21. Connectivity map and PASS-assisted exploration were used to identify compounds whose molecular signatures counteracted those of DS lymphoblasts and to predict their therapeutic potential. An experimental validation in DS LCLs and fetal fibroblasts was performed for the most deregulated GO categories, i.e. the ubiquitin mediated proteolysis and the NF-kB cascade. RESULTS: We show, for the first time, that the level of protein ubiquitination is reduced in human DS cell lines and that proteasome activity is increased in both basal conditions and oxidative microenvironment. We also provide the first evidence that NF-kB transcription levels, a paradigm of gene expression control by ubiquitin-mediated degradation, is impaired in DS due to reduced IkB-alfa ubiquitination, increased NF-kB inhibitor (IkB-alfa) and reduced p65 nuclear fraction. Finally, the DSCR1/DYRK1A/NFAT genes were analysed. In human DS LCLs, we confirmed the presence of increased protein levels of DSCR1 and DYRK1A, and showed that the levels of the transcription factor NFATc2 were decreased in DS along with a reduction of its nuclear translocation upon induction of calcium fluxes. CONCLUSIONS: The present work offers new perspectives to better understand the pathogenesis of DS and suggests a rationale for innovative approaches to treat some pathological conditions associated to DS. |
format | Online Article Text |
id | pubmed-3717290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37172902013-07-21 Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome Granese, Barbara Scala, Iris Spatuzza, Carmen Valentino, Anna Coletta, Marcella Vacca, Rosa Anna De Luca, Pasquale Andria, Generoso BMC Med Genomics Research Article BACKGROUND: Down syndrome (DS) is a complex disorder caused by the trisomy of either the entire, or a critical region of chromosome 21 (21q22.1-22.3). Despite representing the most common cause of mental retardation, the molecular bases of the syndrome are still largely unknown. METHODS: To better understand the pathogenesis of DS, we analyzed the genome-wide transcription profiles of lymphoblastoid cell lines (LCLs) from six DS and six euploid individuals and investigated differential gene expression and pathway deregulation associated with trisomy 21. Connectivity map and PASS-assisted exploration were used to identify compounds whose molecular signatures counteracted those of DS lymphoblasts and to predict their therapeutic potential. An experimental validation in DS LCLs and fetal fibroblasts was performed for the most deregulated GO categories, i.e. the ubiquitin mediated proteolysis and the NF-kB cascade. RESULTS: We show, for the first time, that the level of protein ubiquitination is reduced in human DS cell lines and that proteasome activity is increased in both basal conditions and oxidative microenvironment. We also provide the first evidence that NF-kB transcription levels, a paradigm of gene expression control by ubiquitin-mediated degradation, is impaired in DS due to reduced IkB-alfa ubiquitination, increased NF-kB inhibitor (IkB-alfa) and reduced p65 nuclear fraction. Finally, the DSCR1/DYRK1A/NFAT genes were analysed. In human DS LCLs, we confirmed the presence of increased protein levels of DSCR1 and DYRK1A, and showed that the levels of the transcription factor NFATc2 were decreased in DS along with a reduction of its nuclear translocation upon induction of calcium fluxes. CONCLUSIONS: The present work offers new perspectives to better understand the pathogenesis of DS and suggests a rationale for innovative approaches to treat some pathological conditions associated to DS. BioMed Central 2013-07-05 /pmc/articles/PMC3717290/ /pubmed/23830204 http://dx.doi.org/10.1186/1755-8794-6-24 Text en Copyright © 2013 Granese et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Granese, Barbara Scala, Iris Spatuzza, Carmen Valentino, Anna Coletta, Marcella Vacca, Rosa Anna De Luca, Pasquale Andria, Generoso Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome |
title | Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome |
title_full | Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome |
title_fullStr | Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome |
title_full_unstemmed | Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome |
title_short | Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome |
title_sort | validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and nf-kb in the pathogenesis of down syndrome |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717290/ https://www.ncbi.nlm.nih.gov/pubmed/23830204 http://dx.doi.org/10.1186/1755-8794-6-24 |
work_keys_str_mv | AT granesebarbara validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome AT scalairis validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome AT spatuzzacarmen validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome AT valentinoanna validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome AT colettamarcella validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome AT vaccarosaanna validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome AT delucapasquale validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome AT andriageneroso validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome |